Text messaging to communicate with public health audiences: how the HIPAA Security Rule affects practice.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Karasz HN;Karasz HN; Eiden A; Bogan S
  • Source:
    American journal of public health [Am J Public Health] 2013 Apr; Vol. 103 (4), pp. 617-22. Date of Electronic Publication: 2013 Feb 14.
  • Publication Type:
    Journal Article; Research Support, U.S. Gov't, P.H.S.
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: American Public Health Association Country of Publication: United States NLM ID: 1254074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1541-0048 (Electronic) Linking ISSN: 00900036 NLM ISO Abbreviation: Am J Public Health Subsets: MEDLINE
    • Publication Information:
      Publication: Washington, DC : American Public Health Association
      Original Publication: New York [etc.]
    • Subject Terms:
    • Abstract:
      Text messaging is a powerful communication tool for public health purposes, particularly because of the potential to customize messages to meet individuals' needs. However, using text messaging to send personal health information requires analysis of laws addressing the protection of electronic health information. The Health Insurance Portability and Accountability Act (HIPAA) Security Rule is written with flexibility to account for changing technologies. In practice, however, the rule leads to uncertainty about how to make text messaging policy decisions. Text messaging to send health information can be implemented in a public health setting through 2 possible approaches: restructuring text messages to remove personal health information and retaining limited personal health information in the message but conducting a risk analysis and satisfying other requirements to meet the HIPAA Security Rule.
    • References:
      Nicotine Tob Res. 2009 Aug;11(8):915-23. (PMID: 19542517)
      Am J Prev Med. 2009 Feb;36(2):165-73. (PMID: 19135907)
      Health Psychol. 2010 Jan;29(1):40-9. (PMID: 20063934)
      Vaccine. 2011 Mar 21;29(14):2537-41. (PMID: 21300094)
      N Engl J Med. 2011 Jul 28;365(4):289-91. (PMID: 21793742)
      Aust Health Rev. 2006 Aug;30(3):389-96. (PMID: 16879098)
      Lancet. 2011 Jul 2;378(9785):49-55. (PMID: 21722952)
      J Gen Intern Med. 2006 Aug;21(8):888-90. (PMID: 16881953)
      Lancet. 2010 Nov 27;376(9755):1838-45. (PMID: 21071074)
      Health Serv Res. 2012 Apr;47(2):614-32. (PMID: 22091980)
      Fam Pract. 2006 Dec;23(6):699-705. (PMID: 16916871)
      Arch Dermatol. 2009 Nov;145(11):1230-6. (PMID: 19917951)
      Patient Educ Couns. 2010 Jun;79(3):315-9. (PMID: 20418046)
    • Grant Information:
      P01 TP000297 United States TP OPHPR CDC HHS; 5P01TP000297 United States TP OPHPR CDC HHS
    • Accession Number:
      0 (Influenza Vaccines)
    • Publication Date:
      Date Created: 20130216 Date Completed: 20130516 Latest Revision: 20211021
    • Publication Date:
      20240829
    • Accession Number:
      PMC3673236
    • Accession Number:
      10.2105/AJPH.2012.300999
    • Accession Number:
      23409902